⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

June 1, 2021Journal for ImmunoTherapy of CancerOpen Access

Neoadjuvant nivolumab for patients with resectable HPV-positive and HPV-negative squamous cell carcinomas of the head and neck in the CheckMate 358 trial

View Full Paper

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Abstract

ClinicalTrials.gov NCT02488759; https://clinicaltrials.gov/ct2/show/NCT02488759.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Ferris et al. (2021) studied this question.

synapsesocial.com/papers/69d80b4145af6083e6ae2af3 https://doi.org/10.1136/jitc-2021-002568

View Full Paper

Ask AI

Bookmark

Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Alcohol and head and neck cancer risk in a prospective studyCohort Study · 2007 · 109 citations
2Alcohol Drinking in Never Users of Tobacco, Cigarette Smoking in Never Drinkers, and the Risk of Head and Neck Cancer: Pooled Analysis in the International Head and Neck Cancer Epidemiology ConsortiumCase-Control Study · 2007 · 1,116 citations
3Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United StatesOriginal Research · 2011 · 3,653 citations
4A snapshot of the evolving epidemiology of oropharynx cancersOriginal Research · 2018 · 33 citations
5Detection of Human Papillomavirus-16 in Fine-Needle Aspirates to Determine Tumor Origin in Patients with Metastatic Squamous Cell Carcinoma of the Head and NeckRetrospective Study · 2007 · 257 citations